postoperative emergent reintubations or unanticipated ... · reintubations in the pacu and patients...
TRANSCRIPT
Postoperative Emergent Reintubations or Unanticipated Prolonged Intubation: A Quality Improvement Project
Author: Sarah Clift, RN, BSN, DNAP Candidate
Committee: K. Arndt DNP, CRNA , S. Barenklau DNP, CRNA Support from Dr. Adam Reese MD, Assistant Professor KU
Background
KUMC safely performs 30,000 general anesthetics every year, however there is still concern over the number of emergent reintubations in the PACU and patients that require an unanticipated postoperative ventilator.
Intervention
Ø Chart reviews were performed to seek trends and identify areas for improvement. Ø Key areas for improvement: ideal technique for monitoring neuromuscular blockade
depth and proper dosing of paralytic reversal agents. Ø The Institute of Healthcare Improvement Model for quality improvement methodology
was used to bundle the most effective techniques to prevent CREs. Ø A PowerPoint presentation was given to student nurse anesthetists, along with a
one-page cognitive aid containing the key concepts from the lecture. Ø 5 months later CRE re-evaluated to seek trends and improvement post intervention.
Project Goal reduce the number of CREs by 25% in five months through education of best practices.
Outcome Ø Pre-intervention: 33 CRE Ø Post intervention: 7 CRE
Surpassed goal of 25% reduction
Lessons Learned Ø Overdose of the paralytic reversal, neostigmine, may have contributed to CRE.
Ø Replacement of this drug by sugammadex may have prevented this problem reducing CRE.
Ø Education & Cognitive Aid likely helpful and unlikely harmful
References
Ø Bridion (sugammadex): annotated prescribing information. (2016). Merck & Co., Inc. Retrieved from http://www.merck.com/product/usa /pi_circulars/b /bridion /bridion_pi.pdf
Ø Dorsch J. & Dorsch, S. (2011). Neuromuscular transmission monitoring. In A practical approach to anesthesia equipment. (pp. 500-516). Philadelphia: Lippincott Williams & Wilkins.
Ø Nagelhout, J. (2014). Neuromuscular blocking agents, reversal agents, and their monitoring. In Nagelhout, J. & Plaus, K. (Eds.), Nurse anesthesia (5th ed.) (pp. 158-185). St. Louis: Elsevier Inc.
Ø Pelt, M., Chitilian, H., & Eikerman, M. (2016). Multi-faceted initiative designed to improve safety of neuromuscular blockade. APSF Newsletter, 30, 51-52.
http://www.ihi.org/resources/Pages/HowtoImprove/ScienceofImprovementTestingChanges.aspx
http://www.xavant.com/products/nms450